aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Santi Therapeutics is a pharmaceutical company dedicated to the research and development of small molecule therapeutics. Founded in 2019 and based in Boston, Massachusetts, the company aims to advance medical treatments through innovative drug discovery and development processes.
Since its inception, Santi Therapeutics has made significant strides in the pharmaceutical industry, contributing to the development of new therapies. The company's impact is marked by its commitment to addressing unmet medical needs and improving patient outcomes.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Therapeutics
Technology
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Santi Therapeutics founded?
Santi Therapeutics was founded in 2019.
Where is Santi Therapeutics’s headquarters located?
Santi Therapeutics’s headquarters is located in Boston, MA, US.
When was Santi Therapeutics’s last funding round?
Santi Therapeutics’s most recent funding round was for $10M (USD) in September 2021.
How many employees does Santi Therapeutics have?
Santi Therapeutics has 30 employees as of Feb 4, 2024.
How much has Santi Therapeutics raised to-date?
As of July 05, 2023, Santi Therapeutics has raised a total of $16M (USD) since Sep 17, 2021.
Add Comparison
Total Raised to Date
$16M
USD
Last Update Sep 17, 2021
Last Deal Details
$10M
USD
Sep 17, 2021
Series Unknown
Total Employees Over Time
30
As of Feb 2024
Santi Therapeutics Address
200 Berkeley Street
18th Floor
Boston,
Massachusetts
02116
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts